BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang HY, Xu WQ, Zheng YY, Omari-Siaw E, Zhu Y, Cao X, Tong SS, Yu JN, Xu XM. Octreotide-periplocymarin conjugate prodrug for improving targetability and anti-tumor efficiency: synthesis, in vitro and in vivo evaluation. Oncotarget 2016;7:86326-38. [PMID: 27861145 DOI: 10.18632/oncotarget.13389] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
Number Citing Articles
1 Chatzisideri T, Leonidis G, Sarli V. Cancer-targeted delivery systems based on peptides. Future Med Chem 2018;10:2201-26. [PMID: 30043641 DOI: 10.4155/fmc-2018-0174] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 4.5] [Reference Citation Analysis]
2 Yun W, Qian L, Cheng Y, Tao W, Yuan R, Xu H. Periplocymarin Plays an Efficacious Cardiotonic Role via Promoting Calcium Influx. Front Pharmacol 2020;11:1292. [PMID: 32973521 DOI: 10.3389/fphar.2020.01292] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Zhang H, Wang Q, Sun C, Zhu Y, Yang Q, Wei Q, Chen J, Deng W, Adu-Frimpong M, Yu J, Xu X. Enhanced Oral Bioavailability, Anti-Tumor Activity and Hepatoprotective Effect of 6-Shogaol Loaded in a Type of Novel Micelles of Polyethylene Glycol and Linoleic Acid Conjugate. Pharmaceutics 2019;11:E107. [PMID: 30845761 DOI: 10.3390/pharmaceutics11030107] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 4.3] [Reference Citation Analysis]
4 Yun W, Qian L, Yuan R, Xu H. Periplocymarin protects against myocardial fibrosis induced by β-adrenergic activation in mice. Biomed Pharmacother 2021;139:111562. [PMID: 33839492 DOI: 10.1016/j.biopha.2021.111562] [Reference Citation Analysis]
5 Zhang H, Xu W, Omari-Siaw E, Liu Y, Chen B, Chen D, Yu J, Xu X. Redox-responsive PEGylated self-assembled prodrug-nanoparticles formed by single disulfide bond bridge periplocymarin-vitamin E conjugate for liver cancer chemotherapy. Drug Deliv 2017;24:1170-8. [PMID: 28835137 DOI: 10.1080/10717544.2017.1365393] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
6 Abdellatif AAH, Tolba NS, Alsharidah M, Al Rugaie O, Bouazzaoui A, Saleem I, Ali AT. PEG-4000 formed polymeric nanoparticles loaded with cetuximab downregulate p21 &stathmin-1 gene expression in cancer cell lines. Life Sci 2022;:120403. [PMID: 35176277 DOI: 10.1016/j.lfs.2022.120403] [Reference Citation Analysis]
7 Abdellatif AAH, Ibrahim MA, Amin MA, Maswadeh H, Alwehaibi MN, Al-Harbi SN, Alharbi ZA, Mohammed HA, Mehany ABM, Saleem I. Cetuximab Conjugated with Octreotide and Entrapped Calcium Alginate-beads for Targeting Somatostatin Receptors. Sci Rep 2020;10:4736. [PMID: 32170176 DOI: 10.1038/s41598-020-61605-y] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
8 Zhang H, Zhu Y, Sun C, Xie Y, Adu-frimpong M, Deng W, Yu J, Xu X, Han Z, Qi G. GSH responsive nanomedicines self-assembled from small molecule prodrug alleviate the toxicity of cardiac glycosides as potent cancer drugs. International Journal of Pharmaceutics 2020;575:118980. [DOI: 10.1016/j.ijpharm.2019.118980] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
9 Schneider NFZ, Cerella C, Simões CMO, Diederich M. Anticancer and Immunogenic Properties of Cardiac Glycosides. Molecules 2017;22:E1932. [PMID: 29117117 DOI: 10.3390/molecules22111932] [Cited by in Crossref: 55] [Cited by in F6Publishing: 49] [Article Influence: 11.0] [Reference Citation Analysis]
10 Eltom SEM, Abdellatif AAH, Maswadeh H, Al-Omar MS, Abdel-Hafez AA, Mohammed HA, Agabein EM, Alqasoomi I, Alrashidi SA, Sajid MSM, Mobark MA. The Anti-Inflammatory Effect of a γ-Lactone Isolated from Ostrich Oil of Struthio camelus (Ratite) and Its Formulated Nano-Emulsion in Formalin-Induced Paw Edema. Molecules 2021;26:3701. [PMID: 34204472 DOI: 10.3390/molecules26123701] [Reference Citation Analysis]
11 Figueras E, Martins A, Borbély A, Le Joncour V, Cordella P, Perego R, Modena D, Pagani P, Esposito S, Auciello G, Frese M, Gallinari P, Laakkonen P, Steinkühler C, Sewald N. Octreotide Conjugates for Tumor Targeting and Imaging. Pharmaceutics 2019;11:E220. [PMID: 31067748 DOI: 10.3390/pharmaceutics11050220] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
12 Bejček J, Jurášek M, Spiwok V, Rimpelová S. Quo vadis Cardiac Glycoside Research? Toxins (Basel) 2021;13:344. [PMID: 34064873 DOI: 10.3390/toxins13050344] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
13 Zhang H, Wei S, Zhang Y, Pan A, Adu-Frimpong M, Sun C, Qi G. Improving cellular uptake and bioavailability of periplocymarin-linoleic acid prodrug by combining PEGylated liposome. Drug Deliv 2022;29:2491-7. [PMID: 35912819 DOI: 10.1080/10717544.2022.2104406] [Reference Citation Analysis]
14 Cheng Y, Wang G, Zhao L, Dai S, Han J, Hu X, Zhou C, Wang F, Ma H, Li B, Meng Z. Periplocymarin Induced Colorectal Cancer Cells Apoptosis Via Impairing PI3K/AKT Pathway. Front Oncol 2021;11:753598. [PMID: 34900704 DOI: 10.3389/fonc.2021.753598] [Reference Citation Analysis]